Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind study of Ovula vaginal estriol suppositories vs placebo in vaginal atrophy
2008-003382-22Phase 3Completed
- Sponsor
- DR. KADE Health Care
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estriol in vaginal atrophy (3 arms), sponsored by DR. KADE Health Care. Primary endpoints: Combined primary efficacy endpoint and Safety and tolerability. Started Jul 2008; status: completed.
02
Drugs
estriol
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2008-003382-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003382-22.